Synta Pharmaceuticals Corp. (NASDAQ:SNTA)
CAPS Rating:
A biopharmaceutical company focused on discovering, developing and commercializing small molecule drugs that address severe medical conditions with potential markets, including cancer and chronic inflammatory diseases.
RSS Headlines
Fool UK
Recs
Magic Formula - though speculative. I think it made the MF list because of huge cash infusion from selling its position with another partner.